Research Delivers Insight into the Global Outlook for Lupus Nephritis Market
Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history plays a role in causing the disease. The disease is more common in women compared to men.
Kidney damage from lupus erythematosus can vary from mild to severe. In lupus nephritis, glomeruli or the filtering units are damaged. As a result, waste from the blood does not get filtered. A majority of the patients diagnosed with lupus erythematosus suffer from some kidney damage. The key symptoms of lupus nephritis are flank pain, dark urine, weight gain due to retention of extra fluid, swelling of hands, feet, eyes, and high blood pressure.
Browse Market Research Report @ http://www.transparencymarketresearch.com/lupus-nephritis-market.html
Global Lupus Nephritis Market: Overview
The growing prevalence of lupus nephritis and awareness among patients have propelled the growth of the global lupus nephritis market. Rise in number of clinical trials conducted by key market players and the launch of new biologic drugs will also augment the growth of the global lupus nephritis market. However, prolonged regulatory processes regarding the approval of biologic drugs are likely to hamper the market’s growth in the near future.
To diagnose lupus nephritis, tests such as blood tests, urine tests, and imaging tests, including biopsy and ultrasound, are commonly conducted. There are five different types of lupus nephritis and the treatment depends upon the disease type. Biopsy is the only way to determine the type of lupus nephritis.
Medications used in the treatment of lupus nephritis include immunosuppressive drugs, corticosteroids, and drugs to prevent blood clots and low blood pressure. Corticosteroids are strong anti-inflammatory drugs that are prescribed to improve inflammations caused by lupus nephritis. Immunosuppressive drugs such as azathioprine, cyclophosphamide, and mycophenolate suppress the immune system activity that affects the kidneys. A newer medication, belimumab, is a monoclonal antibody and is prescribed as a biologic drug for the treatment of the disease. Antimalarial drugs are also used to help control the disease. Dialysis and kidney transplant are ultimately prescribed for patients suffering from loss of kidney function even with intake of drugs.
View TOC for this Market Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=10856
Global Lupus Nephritis Market: Region-wise Outlook
The global lupus nephritis market has been segmented into four key regions: North America, Asia Pacific, Europe, and Rest of the World. Robust healthcare infrastructure and research and development activities in developed economies in North America and Europe have propelled the growth of the lupus nephritis market in these regions. The growing prevalence of the disease in North America has also augmented the market growth. It is estimated that about 1.5 million Americans suffer from lupus. In Asia Pacific, the market has registered significant demand with the introduction of biologics.
Some of the key players in the global lupus nephritis market are Roche, Merck, Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline. The key market players are focusing on the development of biologic drugs. Benlysta, developed by GlaxoSmithKline, is the only approved biologic drug in the global lupus nephritis market.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Research Delivers Insight into the Global Outlook for Lupus Nephritis Market here
News-ID: 719589 • Views: 228
More Releases from Transparency Market Research
Water Purifier Market - Competitive Dynamics, Trends, Forecast 2027
Transparency Market Research delivers key insights on the global water purifier market. In terms of revenue, the global water purifier market is estimated to expand at a CAGR of ~ 9% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the water purifier market report. Browse Report Details: https://www.transparencymarketresearch.com/water-purifier-market-2017-2025.html Water purifiers help in removing bacterial contaminants and viruses from water and make it safe
Sheet Face Masks Market Leading Vendors: Sephora Inc. Boss Biological Technique …
The Sheet face masks market promises robust growth during 2018-2026, thanks to rising demand for sheet face mask products. Growing demand for personal hygiene products, and beautification products are expected to drive significant growth. The rising demand for natural ingredients in sheet face masks products is expected to emerge as the largest trend in the market. Browse Report Details: https://www.transparencymarketresearch.com/sheet-face-masks-market.html Sheet face masks are often associated with a certain prestige and rejuvenating
Global Nail Care Market to Reach US$ 20,940.2 Mn by 2027
According to a new research report published by Transparency Market Research titled ‘Nail Care Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027,’ the global nail care market is expected to reach a value of US$ 20,940.2 Mn by 2027, expanding at a CAGR of 8.4% from 2019 to 2027. In terms of volume, the market is expected to reach 1,494.2 Mn units by 2027, expanding at
Industrial Dispensing System and Equipment Market to Reach ~ US$ 16.7 Bn by 2027
Transparency Market Research delivers key insights on the global industrial dispensing system and equipment market. In terms of revenue, the global industrial dispensing system and equipment market is estimated to expand at a CAGR of ~ 6% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the industrial dispensing system and equipment market report. Browse Report Details: https://www.transparencymarketresearch.com/industrial-dispensing-system-equipment-market.html Industrial dispensing systems and equipment are
More Releases for Lupus
Global Systemic Lupus Erythematosus and Lupus Nephritis Drugs Market US$ 1.8 Bil …
The global systemic lupus erythematosus and lupus nephritis drugs market expected to reach US$ 1.8 billion by 2021, growing at CAGR 7.4% over the forecast period 2017-2021. Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that is characterized by systemic chronic inflammation that can affect multiple major organ systems. A major contributor to morbidity and mortality among patients with SLE is renal involvement, known as lupus nephritis (LN). Visit The
Systemic Lupus Erythematosus and Lupus Nephritis Market - Global Drug Forecast a …
Latest industry research report on: Systemic Lupus Erythematosus and Lupus Nephritis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple major organ systems in the
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
Recent research and the current scenario as well as future market potential of "PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 " globally. Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014”. This report provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE)
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" View Full Report : https://www.marketresearchreports.biz/reports/1045237/pharmapoint-systemic-lupus-erythematosus-and-market-research-reports Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune
Lupus Erythematosus Market -API Insights, 2017
Summary Orbis Research Present “Lupus Erythematosus-API Insights, 2017” Description The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage